Advertisement
U.S. Markets closed

Lincoln Pharmaceuticals Limited (LINCOLN.NS)

NSE - NSE Real Time Price. Currency in INR
644.25-16.55 (-2.50%)
At close: 03:30PM IST

Lincoln Pharmaceuticals Limited

Lincoln House
Behind Satyam Complex Science City Road Sola
Ahmedabad 380060
India
91 79 4107 8000
https://www.lincolnpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees1,687

Key Executives

NameTitlePayExercisedYear Born
Mr. Mahendrabhai Gulabdas Patel B.A, LLBMD & Whole Time Director4.92MN/A1954
Mr. Darshit Ashvinkumar ShahChief Financial OfficerN/AN/AN/A
Ms. Trusha K. ShahCompany Secretary & Compliance OfficerN/AN/AN/A
Mr. Ashish Rajnikant PatelWhole Time Director6.64MN/A1981
Mr. Hashmukhbhai Ishwarlal Patel B.sc.Whole Time Director3.81MN/A1958
Mr. Munjal Mahendrabhai PatelWhole Time Director6.65MN/A1982
Mr. Sanjay BhattSenior Manager of OperationN/AN/AN/A
Mr. Laxmikant HarsolaVice President of TechnicalN/AN/AN/A
Mr. Sanjiv PatelSenior Manager of Planning & AdministrationN/AN/AN/A
Mr. Amit Dwivedi B-PHARM, MBAGroup Marketing ManagerN/AN/A1976
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. The company was incorporated in 1979 and is based in Ahmedabad, India.

Corporate Governance

Lincoln Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.